"Clicktophycin-52": A Bioactive Cryptophycin-52 Triazole Analogue

Nahrwold M, Bogner T, Eissler S, Verma S, Sewald N (2010)
ORGANIC LETTERS 12(5): 1064-1067.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ;
Abstract
An endocyclic trans-amide linkage within the macrocyclic antitumor agent cryptophycin-52 was replaced by a 1,4-disubstituted 1H-1,2,3-triazole ring. Macrocyclisation of the triazole analogue was accomplished by macrolactamization as well as by Cu(I)-mediated "click"-cyclization. Compared to cryptophycin-52, in vitro cytotoxicity of "clicktophycin-52" against the multidrug resistant human cancer cell line KB-V1 is only slightly reduced.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Nahrwold M, Bogner T, Eissler S, Verma S, Sewald N. "Clicktophycin-52": A Bioactive Cryptophycin-52 Triazole Analogue. ORGANIC LETTERS. 2010;12(5):1064-1067.
Nahrwold, M., Bogner, T., Eissler, S., Verma, S., & Sewald, N. (2010). "Clicktophycin-52": A Bioactive Cryptophycin-52 Triazole Analogue. ORGANIC LETTERS, 12(5), 1064-1067.
Nahrwold, M., Bogner, T., Eissler, S., Verma, S., and Sewald, N. (2010). "Clicktophycin-52": A Bioactive Cryptophycin-52 Triazole Analogue. ORGANIC LETTERS 12, 1064-1067.
Nahrwold, M., et al., 2010. "Clicktophycin-52": A Bioactive Cryptophycin-52 Triazole Analogue. ORGANIC LETTERS, 12(5), p 1064-1067.
M. Nahrwold, et al., “"Clicktophycin-52": A Bioactive Cryptophycin-52 Triazole Analogue”, ORGANIC LETTERS, vol. 12, 2010, pp. 1064-1067.
Nahrwold, M., Bogner, T., Eissler, S., Verma, S., Sewald, N.: "Clicktophycin-52": A Bioactive Cryptophycin-52 Triazole Analogue. ORGANIC LETTERS. 12, 1064-1067 (2010).
Nahrwold, Markus, Bogner, Tobias, Eissler, Stefan, Verma, Spart, and Sewald, Norbert. “"Clicktophycin-52": A Bioactive Cryptophycin-52 Triazole Analogue”. ORGANIC LETTERS 12.5 (2010): 1064-1067.
This data publication is cited in the following publications:
This publication cites the following data publications:

9 Citations in Europe PMC

Data provided by Europe PubMed Central.

A diversity-oriented synthesis strategy enabling the combinatorial-type variation of macrocyclic peptidomimetic scaffolds.
Isidro-Llobet A, Hadje Georgiou K, Galloway WR, Giacomini E, Hansen MR, Mendez-Abt G, Tan YS, Carro L, Sore HF, Spring DR., Org. Biomol. Chem. 13(15), 2015
PMID: 25778821
Design and synthesis of a new class of cryptophycins based tubulin inhibitors.
Kumar A, Kumar M, Sharma S, Guru SK, Bhushan S, Shah BA., Eur J Med Chem 93(), 2015
PMID: 25647428
Design and synthesis of anti-cancer cyclopeptides containing triazole skeleton.
Tahoori F, Balalaie S, Sheikhnejad R, Sadjadi M, Boloori P., Amino Acids 46(4), 2014
PMID: 24420338
Recent approaches for the synthesis of modified cryptophycins.
Weiss C, Sammet B, Sewald N., Nat Prod Rep 30(7), 2013
PMID: 23732943
Braces for the peptide backbone: insights into structure-activity relationships of protease inhibitor mimics with locked amide conformations.
Tischler M, Nasu D, Empting M, Schmelz S, Heinz DW, Rottmann P, Kolmar H, Buntkowsky G, Tietze D, Avrutina O., Angew. Chem. Int. Ed. Engl. 51(15), 2012
PMID: 22374650
"Triazole bridge": disulfide-bond replacement by ruthenium-catalyzed formation of 1,5-disubstituted 1,2,3-triazoles.
Empting M, Avrutina O, Meusinger R, Fabritz S, Reinwarth M, Biesalski M, Voigt S, Buntkowsky G, Kolmar H., Angew. Chem. Int. Ed. Engl. 50(22), 2011
PMID: 21544910
A two step synthesis of a key unit B precursor of cryptophycins by asymmetric hydrogenation.
Sammet B, Brax M, Sewald N., Beilstein J Org Chem 7(), 2011
PMID: 21448253
Diversity-oriented synthesis of macrocyclic peptidomimetics.
Isidro-Llobet A, Murillo T, Bello P, Cilibrizzi A, Hodgkinson JT, Galloway WR, Bender A, Welch M, Spring DR., Proc. Natl. Acad. Sci. U.S.A. 108(17), 2011
PMID: 21383137

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 20131817
PubMed | Europe PMC

Search this title in

Google Scholar